Haemorrhoids Treatment Market: Rising Awareness and Advancements Driving Global Growth

Introduction

The Haemorrhoids Treatment Market has seen substantial growth in recent years, driven by the rising prevalence of lifestyle-related disorders, sedentary behavior, and increasing awareness about effective medical and surgical treatment options. Haemorrhoids, also known as piles, are swollen veins in the lower rectum or anus, often caused by chronic constipation, obesity, pregnancy, and prolonged sitting.

While haemorrhoids are not typically life-threatening, they can cause significant discomfort and impact quality of life. The growing adoption of minimally invasive procedures and the availability of advanced pharmaceuticals have reshaped the treatment landscape, making it easier for patients to manage and recover from this condition.

Source - https://www.databridgemarketresearch.com/reports/global-hemorrhoids-treatment-market

Market Overview

The global Haemorrhoids Treatment Market was valued at approximately USD 1.9–2.1 billion in 2024 and is projected to reach USD 3.4 billion by 2032, expanding at a compound annual growth rate (CAGR) of around 6.5% during the forecast period.

This growth is primarily attributed to factors such as an aging population, changing dietary habits, and advancements in both drug therapy and surgical equipment. Additionally, public health initiatives and improved diagnostic methods are helping detect cases at earlier stages, thereby improving treatment outcomes.

Key Market Drivers

1. Rising Prevalence of Haemorrhoids

The global incidence of haemorrhoids is increasing due to sedentary lifestyles, low-fiber diets, and growing obesity rates. Studies suggest that more than 40% of adults will experience haemorrhoids at some point in their lives, creating consistent demand for effective treatment options.

2. Increasing Geriatric Population

Older adults are more susceptible to haemorrhoids due to weakened blood vessel walls and reduced physical activity. As the global geriatric population expands, the demand for safe, non-invasive treatments continues to rise.

3. Advancements in Treatment Technologies

Innovations such as laser haemorrhoidoplasty, infrared coagulation, and radiofrequency ablation have transformed the treatment landscape by reducing pain, recovery time, and the risk of recurrence.

4. Growing Preference for Minimally Invasive Procedures

Patients and healthcare providers are increasingly favoring outpatient or minimally invasive techniques that offer faster recovery and fewer complications compared to traditional surgical methods like hemorrhoidectomy.

5. Awareness and Accessibility

Public awareness campaigns and improved access to healthcare services have encouraged more individuals to seek timely treatment, reducing the stigma traditionally associated with this condition.

Market Challenges

Despite positive growth prospects, the haemorrhoids treatment market faces certain challenges that could limit its expansion:

Underreporting Due to Social Stigma – Many patients delay medical consultation due to embarrassment, leading to underdiagnosis.

High Cost of Advanced Procedures – Minimally invasive surgical techniques and new pharmacological formulations can be expensive, limiting access in developing regions.

Side Effects of Medications – Over-the-counter drugs and topical treatments may cause irritation or allergic reactions in some patients.

Recurrence of Symptoms – Even after treatment, recurrence is common if lifestyle changes are not maintained.

Market Segmentation

The Haemorrhoids Treatment Market is segmented by type, treatment modality, route of administration, distribution channel, and region.

By Type

Internal Haemorrhoids – Occur inside the rectum and are the most common type.

External Haemorrhoids – Form under the skin around the anus, often causing pain and irritation.

Mixed Haemorrhoids – A combination of internal and external forms.

By Treatment Modality

Pharmacological Treatment

Topical creams and ointments

Oral medications (pain relievers, venotonics, and laxatives)

Suppositories

Non-Surgical Procedures

Rubber band ligation

Sclerotherapy

Infrared coagulation

Cryotherapy

Surgical Treatment

Hemorrhoidectomy

Stapled hemorrhoidopexy

Laser hemorrhoidoplasty

By Route of Administration

Topical

Oral

Rectal

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Regional Insights

North America

North America dominates the global haemorrhoids treatment market due to a high prevalence of lifestyle-related diseases, well-developed healthcare infrastructure, and the availability of advanced treatment technologies. The United States leads the region, supported by robust insurance coverage and strong R&D investment.

Europe

Europe holds a significant market share owing to the presence of leading pharmaceutical and medical device companies. Countries such as Germany, the UK, and France are key contributors, focusing on the adoption of minimally invasive surgical solutions and increasing patient awareness.

Asia-Pacific

The Asia-Pacific region is expected to witness the fastest growth over the forecast period. Factors such as increasing healthcare expenditure, a growing population, and rising awareness about gastrointestinal health are driving market expansion. Rapid urbanization and changing dietary habits have also led to a rise in haemorrhoid cases across India, China, and Southeast Asia.

Latin America and Middle East & Africa

These regions are experiencing gradual growth, supported by expanding healthcare infrastructure and government initiatives to improve access to medical care. However, limited awareness and affordability issues remain challenges in certain low-income nations.

Market Trends

1. Shift Toward Non-Invasive Treatment Options

Demand for procedures like infrared coagulation and rubber band ligation is increasing, driven by patient preference for faster, less painful solutions.

2. Development of Combination Therapies

Pharmaceutical companies are focusing on combination drugs that offer anti-inflammatory, anesthetic, and vasoconstrictive effects to improve treatment outcomes.

3. Increasing Online Sales of OTC Products

The growth of e-commerce and online pharmacy platforms is boosting access to haemorrhoid treatment products, especially in remote areas.

4. Expansion of Home-Based Care Solutions

Home-use devices and over-the-counter creams are increasingly being adopted by patients seeking privacy and convenience.

5. Investment in Research and Product Innovation

Manufacturers are investing in advanced formulations such as bioactive gels, herbal treatments, and laser-based devices to enhance therapeutic efficacy and minimize side effects.

Competitive Landscape

The haemorrhoids treatment market is moderately fragmented, with several global and regional players. Key participants include:

Pfizer Inc.

Bayer AG

Johnson & Johnson Services, Inc.

Novartis AG

GlaxoSmithKline plc

Sanofi S.A.

Takeda Pharmaceutical Company Limited

Boehringer Ingelheim International GmbH

AbbVie Inc.

Nipro Corporation

These companies focus on strategic collaborations, product innovation, and geographical expansion to strengthen their market position. Recent developments include the introduction of laser-based haemorrhoid treatment devices and natural topical formulations with fewer side effects.

Future Outlook

The Haemorrhoids Treatment Market is expected to continue expanding, fueled by lifestyle changes, healthcare modernization, and an increased focus on patient comfort. The integration of advanced medical technologies, such as laser therapy and AI-assisted diagnostics, will further enhance treatment precision and recovery outcomes.

Emerging economies are likely to contribute significantly to market growth due to improving healthcare access and greater emphasis on gastrointestinal health awareness. Additionally, ongoing research into herbal and natural remedies may offer safer, cost-effective alternatives to traditional medications.

Over the next decade, the market will likely witness:

Broader adoption of outpatient treatment options.

Continuous development of minimally invasive procedures.

Rising acceptance of digital health and teleconsultation platforms for gastrointestinal care.

Conclusion

The Haemorrhoids Treatment Market is poised for steady growth as the global population becomes more health-conscious and access to modern medical solutions improves. With advancements in pharmacology, device technology, and patient care delivery, haemorrhoid management is shifting toward less invasive, more patient-friendly approaches.